This information is intended for healthcare professionals based in Belgium and Luxembourg.

ECLIPSE 1



Dual immunotherapy: Experience in RCC

Prof. Dr. Benoit Beuselinck UZ Leuven, Belgium


Prof. Beuselinck discusses a 55 year old male patient diagnosed with metastatic renal cell carcinoma (RCC). He discusses his approach to managing this patient, including efficacy parameters, as well as management of fatigue & adrenalitis, which was experienced by this patient during treatment.




Dual immunotherapy: Experience in Melanoma

Dr. Mariette Labots Amsterdam UMC, The Netherlands


Dr. Labots discusses a 56 year old male patient diagnosed with melanoma who also has a brain metastasis. She discusses her approach to managing this patient, including efficacy parameters, as well as management of diarrhea & balanitis, which was experienced by this patient during treatment.




Dual immunotherapy: Experience in mNSCLC

Prof. Dr. Jaafar Bennouna CHU Nantes, France


Prof. Bennouna discusses a 59 year old female patient diagnosed with metastatic NSCLC who entered the CM-9LA trial and was randomized to nivo+ipi+chemo arm. He discusses the efficacy and safety outcomes for this patient.





Back to Overview


© 2023 Bristol-Myers Squibb Belgium SA/NV, with its registered office at Chaussée de La Hulpe 185, 1170 Brussels, and having a place of business at Parc de l’Alliance, Avenue de Finlande 4, 1420 Braine-l’Alleud.

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company. ONC-BE-2300035 – Mar/2023

Legal Notice | Privacy Policy | Contact